Supporting the National Action Plan on AMR in Tanzania (SNAP-AMR)
Lead Research Organisation:
University of Glasgow
Department Name: College of Medical, Veterinary, Life Sci
Abstract
Antimicrobial resistance (AMR) is recognised as a global threat to human and animal health, productivity and prosperity. AMR is widespread in both resource-rich nations such as the UK and in low and middle income countries (LMICs). The United Republic of Tanzania is one such LMIC, and in response to a call to action from the World Health Organisation, it has created a National Action Plan (NAP) to combat AMR.
The NAP is an ambitious plan outlining five strategic routes for tackling AMR: i) improved awareness and understanding; ii) enhanced surveillance and research; iii) better sanitation, hygiene and infection prevention; iv) optimized use of antibiotics; and v) sustainable investment in alternatives. In common with many LMICs, the challenge posed by AMR is exacerbated by widespread or unregulated use in both humans and livestock, whilst successful implementation of the NAP is threatened by lack of human and financial resources. Prioritisation of activities and targeting of interventions is therefore an essential component of an effective and efficient campaign to control AMR.
Our research will provide new evidence to support this prioritisation and targeting, taking an approach that recognises that behavioural change is a complex phenomenon depending not just on policy, regulation or knowledge provision but also on cultural background and social norms. Our team of UK and Tanzania-based researchers and policy experts will take an interdisciplinary approach to provide novel insights into the biological, social and cultural drivers influencing antibiotic use in the community and health care system; the spread of AMR between the humans and animals in the community and health care settings; knowledge about AMR; and how to change behaviours to reduce antibiotic use and the spread AMR.
We will contrast doctor prescribing practices in different health care settings (referral hospitals, district hospitals, health centres, dispensaries), as well as investigating community access and attitudes to antibiotics among householders, community 'drug' shops and unregulated sources such as roadside traders. We will use focus groups to examine factors that influence prescribing and usage, e.g. availability of antibiotic drugs, diagnostic facilities, patient demands, medical training and knowledge, coupled with choice-based experiments to establish how best to create change in prescribing behaviour or use. We will also use choice-based experiments to examine use in livestock by individuals with different levels of knowledge about AMR, e.g. district vets, community livestock officers and livestock holders. In parallel, bacterial isolates from people or livestock in hospital and community settings will be DNA-sequenced and examined used genomic tools to establish whether resistant commensal bacteria found in faecal samples in the community are those responsible for illness (respiratory infections, diarrhoea, sepsis and urinary tract infections) in hospitalised children.
The final component will be to assess the knowledge and sources of knowledge held by the public, health care and veterinary workers, policy makers and educators; to design interlinked targeted media campaigns that reflect educational, professional and cultural differences; and to assess the uptake of these materials and their impact on attitudes and approaches to antibiotic drugs and resistance.
The outcomes of our research will help priority setting and targeting in the NAP by identifying the settings (health care system or community) where most effective change can be achieved; showing how to create change in antibiotic usage (e.g. via improved training or education, diagnostic facilities or a social-norm based 'nudge') and identifying the individuals to target to create the most effective change; and by designing and delivering a mass media campaign to create awareness and behavioural change that will help Tanzania to combat the threat posed to its future by AMR.
The NAP is an ambitious plan outlining five strategic routes for tackling AMR: i) improved awareness and understanding; ii) enhanced surveillance and research; iii) better sanitation, hygiene and infection prevention; iv) optimized use of antibiotics; and v) sustainable investment in alternatives. In common with many LMICs, the challenge posed by AMR is exacerbated by widespread or unregulated use in both humans and livestock, whilst successful implementation of the NAP is threatened by lack of human and financial resources. Prioritisation of activities and targeting of interventions is therefore an essential component of an effective and efficient campaign to control AMR.
Our research will provide new evidence to support this prioritisation and targeting, taking an approach that recognises that behavioural change is a complex phenomenon depending not just on policy, regulation or knowledge provision but also on cultural background and social norms. Our team of UK and Tanzania-based researchers and policy experts will take an interdisciplinary approach to provide novel insights into the biological, social and cultural drivers influencing antibiotic use in the community and health care system; the spread of AMR between the humans and animals in the community and health care settings; knowledge about AMR; and how to change behaviours to reduce antibiotic use and the spread AMR.
We will contrast doctor prescribing practices in different health care settings (referral hospitals, district hospitals, health centres, dispensaries), as well as investigating community access and attitudes to antibiotics among householders, community 'drug' shops and unregulated sources such as roadside traders. We will use focus groups to examine factors that influence prescribing and usage, e.g. availability of antibiotic drugs, diagnostic facilities, patient demands, medical training and knowledge, coupled with choice-based experiments to establish how best to create change in prescribing behaviour or use. We will also use choice-based experiments to examine use in livestock by individuals with different levels of knowledge about AMR, e.g. district vets, community livestock officers and livestock holders. In parallel, bacterial isolates from people or livestock in hospital and community settings will be DNA-sequenced and examined used genomic tools to establish whether resistant commensal bacteria found in faecal samples in the community are those responsible for illness (respiratory infections, diarrhoea, sepsis and urinary tract infections) in hospitalised children.
The final component will be to assess the knowledge and sources of knowledge held by the public, health care and veterinary workers, policy makers and educators; to design interlinked targeted media campaigns that reflect educational, professional and cultural differences; and to assess the uptake of these materials and their impact on attitudes and approaches to antibiotic drugs and resistance.
The outcomes of our research will help priority setting and targeting in the NAP by identifying the settings (health care system or community) where most effective change can be achieved; showing how to create change in antibiotic usage (e.g. via improved training or education, diagnostic facilities or a social-norm based 'nudge') and identifying the individuals to target to create the most effective change; and by designing and delivering a mass media campaign to create awareness and behavioural change that will help Tanzania to combat the threat posed to its future by AMR.
Technical Summary
We aim to provide novel insights into the biological, social and cultural drivers of antimicrobial resistance (AMR) that will help policy makers tasked with implementation of the Tanzanian National Action Plan against AMR to prioritise the use of limited human and financial resources via targeted, evidence-based interventions.
We will use qualitative and economic methods to examine antibiotic prescribing and usage in the community and health system, examining practices and attitudes among hospital doctors, community pharmacists, drug shop workers, district veterinary officers, livestock officers and farmers. Key-informant interviews, surveys and focus-group discussions will provide a rich baseline understanding that will inform the design of stated preference choice experiments to identify trade-offs when making choices about antibiotic use and allow prediction of behavioural change given interventions such as a social norm 'nudge' or improved knowledge.
We will examine genomic data from hospital and community-isolated Escherichia coli using phylogenetic analysis, plasmid reconstruction and identification of niche-indicators, to explore the link between hospital and community resistance (especially ESBL), and the link between AMR in human and livestock E. coli. Our findings will provide evidence to prioritise change in antibiotic usage in the community or health care settings, or in the human or livestock context.
We will use social-science and design based approaches to visualise the pathways taken by antibiotic drugs; to capture the exchange of information between stakeholders at different organisational levels in the delivery of government policy; to design, deliver and evaluate a mass media campaign on AMR that recognises the need for change at the individual, community, cultural and societal levels; and provide social-science based media and communications training to build capacity in Tanzania amongst those in public health policy and communication.
We will use qualitative and economic methods to examine antibiotic prescribing and usage in the community and health system, examining practices and attitudes among hospital doctors, community pharmacists, drug shop workers, district veterinary officers, livestock officers and farmers. Key-informant interviews, surveys and focus-group discussions will provide a rich baseline understanding that will inform the design of stated preference choice experiments to identify trade-offs when making choices about antibiotic use and allow prediction of behavioural change given interventions such as a social norm 'nudge' or improved knowledge.
We will examine genomic data from hospital and community-isolated Escherichia coli using phylogenetic analysis, plasmid reconstruction and identification of niche-indicators, to explore the link between hospital and community resistance (especially ESBL), and the link between AMR in human and livestock E. coli. Our findings will provide evidence to prioritise change in antibiotic usage in the community or health care settings, or in the human or livestock context.
We will use social-science and design based approaches to visualise the pathways taken by antibiotic drugs; to capture the exchange of information between stakeholders at different organisational levels in the delivery of government policy; to design, deliver and evaluate a mass media campaign on AMR that recognises the need for change at the individual, community, cultural and societal levels; and provide social-science based media and communications training to build capacity in Tanzania amongst those in public health policy and communication.
Planned Impact
Context: Antimicrobial resistance (AMR) is a major threat to humanity. Most of the direct and indirect impacts of AMR are felt in low- and middle-income countries (LMIC), where basic sanitation and medical provisions are often limited, and treatment of common conditions such as diarrhoea, respiratory disease or urinary tract infection relies on antimicrobials. On the DAC list of ODA recipients, the United Republic of Tanzania (TZ) is classed among the least developed LMIC, and over 30% of its population lives under the national poverty line. To combat AMR and its impacts on people's lives, livelihoods and food security, the World Health Organization adopted a Global Action Plan for AMR, urging all member countries to develop National Action Plans (NAPs). The government of TZ heeded this call and presented its NAP in early 2017. Its 1st objective is to improve awareness and understanding of AMR through effective communication, and the 2nd objective is to strengthen the knowledge and evidence base on AMR through research. Our work aims to support those objectives and, by addressing needs identified by the TZ government, will directly benefit policy makers, professionals and the public.
Policy makers: The NAP includes an analysis of strengths, weaknesses, opportunities and threats. Lack of resources is cited as a major threat to successful implementation of the NAP, whilst inadequate public awareness and communication programmes are recognised as major weaknesses. Implementation of the NAP is coordinated by the AMR Focal point, a unit within the Ministry of Health, Community Development, Gender, Elderly and Children, in collaboration with the Ministry of Agriculture, Livestock and Fisheries and the One Health Coordination Unit under the Prime Minister's Office. Policy makers across those units and ministries are co-investigators and consortium members in our project. They will benefit from our support in development of communication and mass media campaigns on AMR, and from capacity strengthening in media campaign design and impact evaluation. In addition, our research will support prioritisation of audiences and messages to allow for optimal use of limited resources.
Professionals: As prescribers and sellers of antimicrobials for use by people and livestock, the medical, veterinary and pharmaceutical professions play a key role in responsible use of medicines and AMR control. We will work with members of those professions to understand their role in antimicrobial use and drivers of their prescribing behaviour. This provides them with a chance to discuss the pressures and constraints they face in their professional roles as well as their needs, e.g. in development of AMR policy and legislation, communication campaigns for prescribers and users of antimicrobials, or other types of research and capacity strengthening. Moreover, professionals will be benefit from the opportunity to help identify and prioritise the audiences and shape the messages for the media campaign.
Public: The health of all people and animals, in TZ and globally, would benefit from improved control of AMR. Our project, particularly the media campaigns, will help the public understand the threat that AMR poses to their lives, livestock and livelihoods as well as their contribution to the risk of AMR and, importantly, what they can do to reduce that risk. In the UK, in TZ and internationally, massive awareness campaigns are as an essential first step in reducing the demand for antimicrobials. If patients and farmers do not demand antimicrobials, then clinicians, pharmacists, veterinarians and feed mills do not need to feel pressured to prescribe them, dispense them or add them to animal feed unnecessarily. With no major new developments in drug discovery, reduced use and reduced production of antimicrobials are major tools in protecting the public from AMR and safeguarding the efficacy of our existing drugs for future generations.
Policy makers: The NAP includes an analysis of strengths, weaknesses, opportunities and threats. Lack of resources is cited as a major threat to successful implementation of the NAP, whilst inadequate public awareness and communication programmes are recognised as major weaknesses. Implementation of the NAP is coordinated by the AMR Focal point, a unit within the Ministry of Health, Community Development, Gender, Elderly and Children, in collaboration with the Ministry of Agriculture, Livestock and Fisheries and the One Health Coordination Unit under the Prime Minister's Office. Policy makers across those units and ministries are co-investigators and consortium members in our project. They will benefit from our support in development of communication and mass media campaigns on AMR, and from capacity strengthening in media campaign design and impact evaluation. In addition, our research will support prioritisation of audiences and messages to allow for optimal use of limited resources.
Professionals: As prescribers and sellers of antimicrobials for use by people and livestock, the medical, veterinary and pharmaceutical professions play a key role in responsible use of medicines and AMR control. We will work with members of those professions to understand their role in antimicrobial use and drivers of their prescribing behaviour. This provides them with a chance to discuss the pressures and constraints they face in their professional roles as well as their needs, e.g. in development of AMR policy and legislation, communication campaigns for prescribers and users of antimicrobials, or other types of research and capacity strengthening. Moreover, professionals will be benefit from the opportunity to help identify and prioritise the audiences and shape the messages for the media campaign.
Public: The health of all people and animals, in TZ and globally, would benefit from improved control of AMR. Our project, particularly the media campaigns, will help the public understand the threat that AMR poses to their lives, livestock and livelihoods as well as their contribution to the risk of AMR and, importantly, what they can do to reduce that risk. In the UK, in TZ and internationally, massive awareness campaigns are as an essential first step in reducing the demand for antimicrobials. If patients and farmers do not demand antimicrobials, then clinicians, pharmacists, veterinarians and feed mills do not need to feel pressured to prescribe them, dispense them or add them to animal feed unnecessarily. With no major new developments in drug discovery, reduced use and reduced production of antimicrobials are major tools in protecting the public from AMR and safeguarding the efficacy of our existing drugs for future generations.
Organisations
- University of Glasgow (Lead Research Organisation)
- Government of Tanzania (Collaboration)
- Washington State University (Collaboration)
- University of Calgary (Collaboration)
- Kilimanjaro Christian Medical Centre (KCMS) (Collaboration)
- Bugando Medical Centre (Collaboration)
- Nelson Mandela African Institute for Science and Technology (Collaboration)
- UNIVERSITY OF SYDNEY (Collaboration)
Description | This award has enabled the development of an research consortium of biomedical, quantitative and social scientists from Tanzania and the UK. This research consortium is now leading a major project on antimicrobial resistance in Tanzania and supporting the National Action Plan on antimicrobial resistance in the country. |
Exploitation Route | This question is not appropriate for the type of award. |
Sectors | Agriculture Food and Drink Healthcare |
Description | The findings from this start-up grant have been used to inform a multi-year program of work on Supporting the National Action Plan for Antimicrobial Resistance in Tanzania. |
First Year Of Impact | 2018 |
Sector | Healthcare |
Impact Types | Societal |
Description | An integrated approach to tackling drug resistance in livestock trypanosomes. |
Amount | £343,273 (GBP) |
Funding ID | BB/S000143/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 01/2019 |
End | 12/2020 |
Description | Enabling optimal antimicrobial use in East Africa |
Amount | £128,259 (GBP) |
Funding ID | EP/T024984/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 05/2020 |
End | 05/2022 |
Description | Supporting the National Action Plan for Antimicrobial Resistance (SNAP-AMR) in Tanzania |
Amount | £3,189,370 (GBP) |
Funding ID | MR/S004815/1 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 04/2018 |
End | 04/2023 |
Description | BMC |
Organisation | Bugando Medical Centre |
Country | Tanzania, United Republic of |
Sector | Hospitals |
PI Contribution | We initiated collaboration with Bugando Medical Centre in Mwanza, Tanzania. We visited BMC and met with key administrative contacts. We have since set up an MoU with BMC and involved BMC as a partner on an MRC grant application. |
Collaborator Contribution | Professor Stephen Mshana from Bugando Medical Centre participated in several workshops on AMR, hosted a visit by delegates from the University of Glasgow, facilitated the signing of an MoU and contributed to the writing of a grant proposal that is under consideration by MRC. His team will also contribute Klebsiella isolates to the MRC funded SpARK project, funded as JPI-AMR project and led by Prof. Ed Feil at the University of Bath. |
Impact | This collaboration is multi-disciplinary and involves one or more representatives of the following disciplines: anthropology, epidemiology, genomics, health economics, human geography, mathematics, medical science, microbiology, pharmacology, sociology, veterinary medicine |
Start Year | 2017 |
Description | Calgary |
Organisation | University of Calgary |
Country | Canada |
Sector | Academic/University |
PI Contribution | We approached the partner, engaged in discussions, and invited them to contribute to a grant application. |
Collaborator Contribution | The University of Calgary shared expertise and ideas with us to inform the writing of a grant application, on which a member of their staff is a co-investigator. |
Impact | Interdisciplinary grant application involving one or more representatives of the following disciplines: anthropology, epidemiology, genomics, health economics, human geography, mathematics, medicine, microbiology, pharmacology, sociology, veterinary medicine |
Start Year | 2017 |
Description | HAZEL-NMAIST |
Organisation | Nelson Mandela African Institute for Science and Technology |
Country | Tanzania, United Republic of |
Sector | Academic/University |
PI Contribution | I led the write up of the grant proposal HAZEL; submitted under the ZELS call, with contributions from my research team. |
Collaborator Contribution | Prof. Paul Gwakisa contributed to the writing of the grant proposal HAZEL that was submitted under the ZELS call. NMAIST hosted the launch meeting in Arusha, Tanzania, in December 2014. Professor Joram Buza has since taken over as lead contact for this project. Prof Buza participated in the BBSRC-DfiD ZELS launch meeting in London, 10 November 2014, and in a project specific meeting in London, 11 November 2014. Prof Buza contributes regularly to project discussions and hosted the 2017 Grantholders' Meeting at NM-AIST. |
Impact | Successful application for the HAZEL project funding. This is a multi-disciplinary collaboration involving medics, veterinarians, quantitative scientists, social scientists, and molecular epidemiologists. Successful application for funding of the Afrique One ASPIRE project Co-supervision of an MSc project: Assessment of risk factors that lead to prevalence of Salmonella and Campylobacter in chicken managed in different production systems Co-supervision of a PhD project: Development of surveillance and typing schemes for anthrax epidemiological studies in endemic areas Conference Presentations: Thomas KM, Crump JA, Benschop J, Buza J, Cleaveland S, French N, Karimuribo E, Kazwala R, Mmbaga B, Mtui N, Prinsen G, Sharp J, Swai E, Zadoks R. 2016. Hazards Associated with Zoonotic enteric pathogens in Emerging Livestock meat pathways (HAZEL) - Understanding meat safety in Tanzania through a One Health approach. Abstract number OR-VF-025. FoodMicro2016. 25th International Committee on Food Microbiology and Hygiene Conference. Dublin, Ireland. 19-22 July 2016. R. Zadoks, K. Thomas, G. Barker, J. Benschop, J. Buza, S. Cleaveland, M. Davis, N. French, E. Karimuribo, R. Kazwala, B. Mmbaga, N. Mtui, G. Prinsen, J. Sharp, E. Swai, L. Waldman, J. Crump. Of Meat and Men, Models and Microbes - Understanding Salmonella risks in Tanzania's Meat Supply Chain. . 34th Tanzania Veterinary Association Conference, 6-8 December 2016, Arusha, Tanzania. Audience: veterinarians, policy makers, PhD students, researchers. |
Start Year | 2012 |
Description | KCMC |
Organisation | Kilimanjaro Christian Medical Centre (KCMS) |
Country | Tanzania, United Republic of |
Sector | Hospitals |
PI Contribution | I led the write up of the grant proposal HAZEL; submitted under the ZELS call, with contributions from my research team. I also led the writing of the SNAP-AMR consortium building grant and the full SNAP-AMR grant with KCMC as partner. |
Collaborator Contribution | Prof. Moshi Ntabaye contributed to the writing of the grant proposal HAZEL; that was submitted under the ZELS call. Prof. Gibson Kibiki initially took over as the main collaborator and he helped our team to implement a BSL2 laboratory for testing of samples of animal origin at the Kilimanjaro Clinical Research Institute where the laboratory component of our project will be based. Gibson Kibiki was replaced by Prof Blandina Mmbaga in mid-2015, and has contributed intellectually to the ongoing research. Prof Mmbaga attends monthly skype calls and attended two ZELS grantholders' workshop' in 2015 (Cambridge) and 2017 (Arusha). Prof Mmbaga contributed to writing of the SNAP-AMR consortium building and full grant proposals. |
Impact | Successful funding application for the HAZEL project Operationalization of a new Zoonoses Laboratory at the Kilimanjaro Clinical Research Institute Successful application for Afrique One ASPIRE project funding Successful application for Marie Curie Fellowship (MEBA - DLV-659223): Molecular epidemiology of Bacillus anthracis: novel data and techniques for local surveillance in Tanzania. Fellow: Taya Forde (UoG). Lab work is being conducted at the Zoonoses Laboratory UoG undergraduate veterinary student Milou Nijenhuis conducted a placement in the Zoonoses Lab in Moshi. Co-Supervision of PhD Student: Development of surveillance and typing schemes for anthrax epidemiological studies in endemic areas Conference Presentations: Thomas KM, Crump JA, Benschop J, Buza J, Cleaveland S, French N, Karimuribo E, Kazwala R, Mmbaga B, Mtui N, Prinsen G, Sharp J, Swai E, Zadoks R. 2016. Hazards Associated with Zoonotic enteric pathogens in Emerging Livestock meat pathways (HAZEL) - Understanding meat safety in Tanzania through a One Health approach. Abstract number OR-VF-025. FoodMicro2016. 25th International Committee on Food Microbiology and Hygiene Conference. Dublin, Ireland. 19-22 July 2016. R. Zadoks, K. Thomas, G. Barker, J. Benschop, J. Buza, S. Cleaveland, M. Davis, N. French, E. Karimuribo, R. Kazwala, B. Mmbaga, N. Mtui, G. Prinsen, J. Sharp, E. Swai, L. Waldman, J. Crump. Of Meat and Men, Models and Microbes - Understanding Salmonella risks in Tanzania's Meat Supply Chain. . 34th Tanzania Veterinary Association Conference, 6-8 December 2016, Arusha, Tanzania. Audience: veterinarians, policy makers, PhD students, researchers. |
Start Year | 2012 |
Description | MoHCDGEC-TZ |
Organisation | Government of Tanzania |
Department | Ministry of Health, Community Development, Gender, Elderly and Children |
Country | Tanzania, United Republic of |
Sector | Public |
PI Contribution | At the recommendation of TZ partners, I made contact with the AMR focal point, who then became a co-investigator. |
Collaborator Contribution | As co-investigator, the AMR focal point contributed to development of the grant proposal. |
Impact | Grant application for MRC AMR consortium building grant. Grant application for MRC AMR full consortium grant. |
Start Year | 2017 |
Description | Sharing/collaboration on Klebsiella sequences |
Organisation | Washington State University |
Country | United States |
Sector | Academic/University |
PI Contribution | A BBSRC funded project in Tanzania has provided Klebsiella isolates for sequencing which will provide input into SPARK plus and a currently funded MRC funded project in Tanzania looking at the drivers of antibtioic resistance. |
Collaborator Contribution | A BBSRC funded project in Tanzania has provided Klebsiella isolates for sequencing which will provide input into SPARK plus and a currently funded MRC funded project in Tanzania looking at the drivers of antibtioic resistance. |
Impact | Analysis of sequence data in progress. |
Start Year | 2019 |
Description | UofG-USYD |
Organisation | University of Sydney |
Department | Faculty of Veterinary Science |
Country | Australia |
Sector | Academic/University |
PI Contribution | Prof Zadoks was lead applicant (HAZEL; SNAP-AMR) or co-applicant on the proposals listed in ResearchFish and continues to contribute to ongoing activities despite having moved to the University in Sydney. The University of Sydney covers her salary as in-kind contribution to enable her to continue to contribute to meetings, publications, ResearchFish reporting, etc. |
Collaborator Contribution | All listed projects were initiated by the partners, including by Prof. Zadoks when she was still employed by the University of Glasgow. |
Impact | Prof. Zadoks continues to engage with several projects, including through meetings, preparation of manuscripts, and reporting in ResearchFish. Prof. Zadoks' time investment in various projects is still significant and is contributed in-kind by her current employer, the University of Sydney. Multiple disciplines are involved in each project, as reported under various projects where appropriate. |
Start Year | 2019 |
Description | WSU |
Organisation | Washington State University |
Country | United States |
Sector | Academic/University |
PI Contribution | I led the write up of the grant proposal HAZEL, submitted under the ZELS call, with contributions from my research team incl. Dr Margaret Davis at WSU. Prof Douglas Call, also at WSU, led a NSF-BBSRC project on AMR in Northern Tanzania and Klebsiella isolates or sequences from that project will be included in data analysis under SpARK. |
Collaborator Contribution | Dr. Margaret Davis contributed to the writing of the grant proposal HAZEL; that was submitted under the ZELS call. Dr Davis contributes intellectual input into project activities and attends annual in-person meetings and monthly skype calls. Conference Presentations: G. Prinsen, J. Benschop, N. French, E. Swai, R. Zadoks, J. Sharp, L. Waldman. Food Safety Awareness and Practices in Urban and Rural Butcheries and Eateries in Northern Tanzania. 34th Tanzania Veterinary Association Conference, 6-8 December 2016, Arusha, Tanzania. Audience: veterinarians, policy makers, PhD students, researchers. G. Prinsen, J. Benschop, N. French, E. Swai, R. Zadoks, J. Sharp, L. Waldman. Food Safety Awareness and Practices in Urban and Rural Butcheries and Eateries in Northern Tanzania. 9th Biennial Conference New Zealand International Development Studies Network, 5-7 December 2016, Wellington, New Zealand. Audience: researchers, development experts. R. Zadoks, K. Thomas, G. Barker, J. Benschop, J. Buza, S. Cleaveland, M. Davis, N. French, E. Karimuribo, R. Kazwala, B. Mmbaga, N. Mtui, G. Prinsen, J. Sharp, E. Swai, L. Waldman, J. Crump. Of Meat and Men, Models and Microbes - Understanding Salmonella risks in Tanzania's Meat Supply Chain. . 34th Tanzania Veterinary Association Conference, 6-8 December 2016, Arusha, Tanzania. Audience: veterinarians, policy makers, PhD students, researchers. Since then, the collaboration has been extended to include Professor Douglas Call, who has shared a collection of ~600 AMR resistant E. coli isolates with us to inform writing of a follow-on grant proposal. He is also contributing material to the Klebsiella-focussed SpARK project, funded by MRC through a JPI-AMR grant. |
Impact | (1) Successful application for funding of the HAZEL project. This is a multi-disciplinary collaboration involving medics, veterinarians, quantitative scientists, social scientists, and molecular epidemiologists. (2) Submission of a grant application to MRC. This is a multi-disciplinary collaboration involving representatives of the following disciplines: anthropology, bioinformatics, health economics, epidemiology, human geography, mathematics, medicine, microbiology, pharmacology, sociology, veterinary medicine |
Start Year | 2012 |
Description | Antimicrobial Resistance - Genomes, Big Data and Emerging Technologies, Wellcome Genome - Poster |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Event: Antimicrobial Resistance - Genomes, Big Data and Emerging Technologies, 27-29 November 2018, Hinxton Authors: Mshana S1, Laurie E2, McIntosh E2, Shirima G3, Davis A2, Lembo T2, Hanley N2, Mmbaga BT4, Matthews L2, Oravcova K2, Mapunjo S5, Hilton S2, Van der Meer F6, Call DR7, Zadoks RN2 Title: Supporting the National Action Plan on AMR in Tanzania - SNAP-AMR |
Year(s) Of Engagement Activity | 2018 |
Description | Invited presentation at Infection Biology symposium, Calgary |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Invited presentation at Infection Biology symposium, University of Calgary, 6-7 September 2018. |
Year(s) Of Engagement Activity | 2018 |
Description | SNAP_AMR consortium building workshop |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Workshop to develop SNAP-AMR consortium proposal held at the Kilimanjaro Clinical Research Institute (KCRI) in Moshi, Tanzania, with representation from KCRI; Kilimanjaro Christian Medical Centre, Moshi; Catholic University of Health and Allied Sciences/Bugando Medical Centre, Mwanza; Nelson Mandela African Institution of Science and Technology, Arusha; media expert Fauziyat Abood, Dar es Salaam; AMR Focal Point for Tanzania, Dar es Salaam; and University of Glasgow (College of Medical Veterinary and Life Sciences, College of Science and Engineering, MRC/CSO Social and Public Health Sciences Unit). |
Year(s) Of Engagement Activity | 2017 |
Description | SNAP_AMR policy visit Tanzania November 2017 |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Policymakers/politicians |
Results and Impact | Formal dialogue with Tanzanian policy partners and representatives from the medical profession about design of full SNAP-AMR consortium. Representation from FAO-Tanzania, Ministry of Health Community Development Gender Elderly and Chilren, Ministry of Livestock and Fisheries, Codex Alimentarius committee, Muhimibili Universit of Health and Allied Science, AMR Focal point Tanzania. |
Year(s) Of Engagement Activity | 2017 |
Description | SNAP_AMR presentation SM in Glasgow |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Postgraduate students |
Results and Impact | Invited lecture by SNAP_AMR team member Prof. S. Mshana about antimicrobial resistance (AMR) in Tanzania |
Year(s) Of Engagement Activity | 2018 |
Description | University visit (Massey University) - Presentation on Balancing facts and perceptions in AMR research |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Presentation to Massey University staff and students, organized by co-investigator on HAZEL project, to present results from AMR projects in Tanzania and the UK and to explore opportunities for collaboration with subsequent contact with FAO-RAP and Fleming Fund around future AMR-related activities. |
Year(s) Of Engagement Activity | 2019 |